- Nachrichtendetail
-
30.05.2024 19:00:42 - dpa-AFX: EQS-News: Medacta 25th Anniversary World Tour continues with events in Australia and the United States focusing on Personalized and Sustainable Total Knee Arthroplasty (english)
Medacta 25th Anniversary World Tour continues with events in Australia and
the United States focusing on Personalized and Sustainable Total Knee
Arthroplasty
Medacta Group SA / Key word(s): Miscellaneous/Miscellaneous
Medacta 25th Anniversary World Tour continues with events in Australia and
the United States focusing on Personalized and Sustainable Total Knee
Arthroplasty
30.05.2024 / 19:00 CET/CEST
---------------------------------------------------------------------------
MEDIA RELEASE
Medacta 25th Anniversary World Tour continues with events in Australia and
the United States focusing on Personalized and Sustainable Total Knee
Arthroplasty
CASTEL SAN PIETRO, May 30, 2024 - On the occasion of its 25th anniversary,
Medacta Group SA ("Medacta," SIX:MOVE) announces the 4th Australian M.O.R.E.
Knee Symposium in Sydney (AU) which will take place from May 30 to June 1,
2024, and the 2nd Kinematic Alignment Summit in Chicago (US) scheduled for
June 7-8. These two events are part of a global scientific series, following
the successful 10th M.O.R.E. International Symposium, held in Lugano,
Switzerland, from April 15-19, 2024, focused on "the sustainability of
personalized medicine and technology in orthopedics and spine surgery.".
"We are honored to welcome surgeons from all over the world and pleased to
continue celebrating our 25th anniversary by hosting these upcoming
scientific events focused on the knee, the segment that has changed the most
for Medacta over the past five years, with our expanding and proven
expertise in Kinematic Alignment" states Francesco Siccardi, CEO of Medacta
"These events underscore our commitment and dedication to medical education,
promoting the sharing of experience and knowledge among distinguished
surgeons from around the world to improve care, outcomes, and patient
well-being."
"It's important to leverage a comprehensive and versatile knee portfolio to
help my patients during the different stages of knee pathologies," says Dr.
Bu Balalla, Sydney, Australia. The 4th Australian M.O.R.E. Knee Symposium
perfectly aligns with this approach, exploring the latest advancements in
knee procedures, covering topics from sports medicine to revision, with the
aim of improving both natural joint motion and biomechanics, ultimately
leading to improved patient outcomes. The complete Medacta knee portfolio
supports surgeons with an innovative, personalized, and sustainable
offering. It leverages the integration of MySolutions Personalized Ecosystem
technologies, including the NextAR Knee Augmented Reality surgical
application and MyKnee Patient-Matched solution, with the GMK Efficiency
single-use instrument, holding the promise of improving accuracy, precision,
and efficiency in knee surgeries.
Moreover, these scientific events will bring together renowned experts in
the field to explore innovative approaches to knee arthroplasty, with a
particular focus on Kinematic Alignment. "Kinematic Alignment has become one
of the most-discussed concepts in TKA. Growing out of the desire to deliver
a personalized approach to arthroplasty, KA has shown promising results in
published literature with the potential to positively impact patient
outcomes," states Dr. Keith Berend, New Albany, Ohio, USA. Kinematic
Alignment, a surgical technique designed to restore the knee's function to
its pre-arthritic state, has been shown to improve patient outcomes through
numerous peer-reviewed studies. The event in the United States provides the
perfect opportunity to discuss the initial results of the GMK SpheriKA
implant, the first knee implant specifically designed for Kinematic
Alignment procedures. Additionally, Medacta's MyKA platform offers surgeons
a comprehensive solution to perform Kinematic Alignment safely and
consistently.
As Medacta celebrates its 25th anniversary this year, CEO Francesco Siccardi
reflects on the company's ongoing commitment to medical education and
innovation: "We are proud to celebrate our 25th anniversary by continuing to
support our solutions and technologies through world-class medical
education. Our dedication to advancing orthopedic care is unwavering, and we
remain focused on what matters the most: improving patient outcomes
worldwide."
Medacta 25th Anniversary World Tour concludes in Tokyo from October 12th to
14th.
For more information:
* Medacta's 10th MORE International Symposium announcement
* Medacta's 10th MORE International Symposium website
* Medacta's history
Contact
Gianluca Olgiati
Group Vice President Marketing
+41 91 696 60 60
media@medacta.ch
Medacta is a global key player specializing in the design, production, and
distribution of innovative, personalized, and sustainable solutions for
joint replacement, sports medicine, and spine surgery. Established in 1999
in Switzerland, Medacta is committed to improving the care and well-being of
patients and maintains a strong focus on healthcare sustainability. Through
close collaboration with expert surgeons globally, continuous investments in
R&D, and the adoption of cutting-edge technologies, Medacta's innovation
prioritizes minimally invasive surgery and personalized solutions for every
patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a
comprehensive and tailored program dedicated to the advancement of medical
education. Medacta is headquartered in Castel San Pietro, Switzerland, and
operates in over 60 countries. Follow us on Medacta TV, YouTube, LinkedIn
and X.
RELATED TRADEMARKS
Medacta Group Related Trademarks are registered at least in Switzerland. The
products and services listed below may not be all-inclusive, and other
Medacta products and services not listed below may be covered by one or more
trademarks. The below products and services may be covered by additional
trademarks not listed below. Note that Swiss trademarks may have foreign
counterparts. MySolutions(TM) Personalized Ecosystem, NextAR(TM), GMK®SpheriKA.
---------------------------------------------------------------------------
Additional features:
File: https://eqs-cockpit.com/c/fncls.ssp?u=cd25c5bf1456222a1507af28ab04d930
File description: Medacta 25th Anniversary World Tour continues with events
in Australia and the United States
---------------------------------------------------------------------------
End of Media Release
---------------------------------------------------------------------------
End of News EQS News Service
---------------------------------------------------------------------------
1913935 30.05.2024 CET/CEST
the United States focusing on Personalized and Sustainable Total Knee
Arthroplasty
Medacta Group SA / Key word(s): Miscellaneous/Miscellaneous
Medacta 25th Anniversary World Tour continues with events in Australia and
the United States focusing on Personalized and Sustainable Total Knee
Arthroplasty
30.05.2024 / 19:00 CET/CEST
---------------------------------------------------------------------------
MEDIA RELEASE
Medacta 25th Anniversary World Tour continues with events in Australia and
the United States focusing on Personalized and Sustainable Total Knee
Arthroplasty
CASTEL SAN PIETRO, May 30, 2024 - On the occasion of its 25th anniversary,
Medacta Group SA ("Medacta," SIX:MOVE) announces the 4th Australian M.O.R.E.
Knee Symposium in Sydney (AU) which will take place from May 30 to June 1,
2024, and the 2nd Kinematic Alignment Summit in Chicago (US) scheduled for
June 7-8. These two events are part of a global scientific series, following
the successful 10th M.O.R.E. International Symposium, held in Lugano,
Switzerland, from April 15-19, 2024, focused on "the sustainability of
personalized medicine and technology in orthopedics and spine surgery.".
"We are honored to welcome surgeons from all over the world and pleased to
continue celebrating our 25th anniversary by hosting these upcoming
scientific events focused on the knee, the segment that has changed the most
for Medacta over the past five years, with our expanding and proven
expertise in Kinematic Alignment" states Francesco Siccardi, CEO of Medacta
"These events underscore our commitment and dedication to medical education,
promoting the sharing of experience and knowledge among distinguished
surgeons from around the world to improve care, outcomes, and patient
well-being."
"It's important to leverage a comprehensive and versatile knee portfolio to
help my patients during the different stages of knee pathologies," says Dr.
Bu Balalla, Sydney, Australia. The 4th Australian M.O.R.E. Knee Symposium
perfectly aligns with this approach, exploring the latest advancements in
knee procedures, covering topics from sports medicine to revision, with the
aim of improving both natural joint motion and biomechanics, ultimately
leading to improved patient outcomes. The complete Medacta knee portfolio
supports surgeons with an innovative, personalized, and sustainable
offering. It leverages the integration of MySolutions Personalized Ecosystem
technologies, including the NextAR Knee Augmented Reality surgical
application and MyKnee Patient-Matched solution, with the GMK Efficiency
single-use instrument, holding the promise of improving accuracy, precision,
and efficiency in knee surgeries.
Moreover, these scientific events will bring together renowned experts in
the field to explore innovative approaches to knee arthroplasty, with a
particular focus on Kinematic Alignment. "Kinematic Alignment has become one
of the most-discussed concepts in TKA. Growing out of the desire to deliver
a personalized approach to arthroplasty, KA has shown promising results in
published literature with the potential to positively impact patient
outcomes," states Dr. Keith Berend, New Albany, Ohio, USA. Kinematic
Alignment, a surgical technique designed to restore the knee's function to
its pre-arthritic state, has been shown to improve patient outcomes through
numerous peer-reviewed studies. The event in the United States provides the
perfect opportunity to discuss the initial results of the GMK SpheriKA
implant, the first knee implant specifically designed for Kinematic
Alignment procedures. Additionally, Medacta's MyKA platform offers surgeons
a comprehensive solution to perform Kinematic Alignment safely and
consistently.
As Medacta celebrates its 25th anniversary this year, CEO Francesco Siccardi
reflects on the company's ongoing commitment to medical education and
innovation: "We are proud to celebrate our 25th anniversary by continuing to
support our solutions and technologies through world-class medical
education. Our dedication to advancing orthopedic care is unwavering, and we
remain focused on what matters the most: improving patient outcomes
worldwide."
Medacta 25th Anniversary World Tour concludes in Tokyo from October 12th to
14th.
For more information:
* Medacta's 10th MORE International Symposium announcement
* Medacta's 10th MORE International Symposium website
* Medacta's history
Contact
Gianluca Olgiati
Group Vice President Marketing
+41 91 696 60 60
media@medacta.ch
Medacta is a global key player specializing in the design, production, and
distribution of innovative, personalized, and sustainable solutions for
joint replacement, sports medicine, and spine surgery. Established in 1999
in Switzerland, Medacta is committed to improving the care and well-being of
patients and maintains a strong focus on healthcare sustainability. Through
close collaboration with expert surgeons globally, continuous investments in
R&D, and the adoption of cutting-edge technologies, Medacta's innovation
prioritizes minimally invasive surgery and personalized solutions for every
patient. Through the M.O.R.E. Institute, Medacta supports surgeons with a
comprehensive and tailored program dedicated to the advancement of medical
education. Medacta is headquartered in Castel San Pietro, Switzerland, and
operates in over 60 countries. Follow us on Medacta TV, YouTube, LinkedIn
and X.
RELATED TRADEMARKS
Medacta Group Related Trademarks are registered at least in Switzerland. The
products and services listed below may not be all-inclusive, and other
Medacta products and services not listed below may be covered by one or more
trademarks. The below products and services may be covered by additional
trademarks not listed below. Note that Swiss trademarks may have foreign
counterparts. MySolutions(TM) Personalized Ecosystem, NextAR(TM), GMK®SpheriKA.
---------------------------------------------------------------------------
Additional features:
File: https://eqs-cockpit.com/c/fncls.ssp?u=cd25c5bf1456222a1507af28ab04d930
File description: Medacta 25th Anniversary World Tour continues with events
in Australia and the United States
---------------------------------------------------------------------------
End of Media Release
---------------------------------------------------------------------------
Language: English
Company: Medacta Group SA
Strada Regina
6874 Castel San Pietro
Switzerland
Phone: +41 91 696 6060
E-mail: info@medacta.ch
Internet: www.medacta.com
ISIN: CH0468525222
Listed: SIX Swiss Exchange
EQS News ID: 1913935
End of News EQS News Service
---------------------------------------------------------------------------
1913935 30.05.2024 CET/CEST
